aplaviroc: Clinical Trials

3 trials of aplaviroc, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 1 completed. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Terminated 2, Completed 1

Follow aplaviroc: new trials by email Literature Review of aplaviroc trials Research Report on aplaviroc

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
GW873140 In Combination With Combivir In HIV Infected Subjects
GW873140, Combivir - Infection, Human Immunodeficiency Virus I, HIV Infection
Phase 2TerminatedViiV Healthcare1252005-01-012017-05-30
GW873140 In Combination With Kaletra In HIV Infected Subjects
GW873140, Kaletra (lopinavir/ritonavir) - Infection, Human Immunodeficiency Virus I, HIV Infection
Phase 2TerminatedViiV Healthcare1752004-12-012017-05-30
GW873140 to Treat HIV-1 Infected Adults
GW873140 - HIV Infections
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)202004-01-012008-03-04

Conditions studied

HIV Infections (3)  ·  Infections (2)

Sponsors

ViiV Healthcare (2)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)

Countries

United States (3)  ·  Canada (2)  ·  France (2)  ·  Germany (2)  ·  Italy (2)  ·  Portugal (2)  ·  Spain (2)  ·  United Kingdom (2)  ·  Belgium (1)  ·  Denmark (1)  ·  Netherlands (1)